Benzinga's Top Ratings Upgrades, Downgrades For December 27, 2022
Benzinga's Top Ratings Upgrades, Downgrades For December 27, 2022
Upgrades
See all analyst ratings upgrades.
Downgrades
For Applied Molecular Transport Inc (NASDAQ:AMTI), SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the third quarter, Applied Molecular showed an EPS of $0.65, compared to $0.68 from the year-ago quarter. The stock has a 52-week-high of $14.94 and a 52-week-low of $0.39. At the end of the last trading period, Applied Molecular closed at $0.43.
See all analyst ratings downgrades.
Initiations
Northland Capital Markets initiated coverage on The Lion Electric Co (NYSE:LEV) with an Outperform rating. The price target for Lion Electric is set to $5.00. Lion Electric earned $0.09 in the third quarter, compared to $0.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of $10.18 and a 52-week-low of $1.83. Lion Electric closed at $2.00 at the end of the last trading period.
With a Buy rating, Chardan Capital initiated coverage on Gesher I Acquisition Corp (NASDAQ:GIAC). The price target seems to have been set at $13.00 for Gesher I Acquisition.
Chardan Capital initiated coverage on Century Therapeutics Inc (NASDAQ:IPSC) with a Buy rating. The price target for Century Therapeutics is set to $19.00. Century Therapeutics earned $0.53 in the third quarter, compared to $0.48 in the year-ago quarter. The stock has a 52-week-high of $19.39 and a 52-week-low of $5.48. At the end of the last trading period, Century Therapeutics closed at $5.67.
See all analyst ratings initiations.
Upgrades
升級
See all analyst ratings upgrades.
查看所有分析師評級升級。
Downgrades
降級
For Applied Molecular Transport Inc (NASDAQ:AMTI), SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the third quarter, Applied Molecular showed an EPS of $0.65, compared to $0.68 from the year-ago quarter. The stock has a 52-week-high of $14.94 and a 52-week-low of $0.39. At the end of the last trading period, Applied Molecular closed at $0.43.
對於 应用分子运输公司 (納斯達克:AMTI), SVB 利蘭克將之前的「跑贏大市場表現」評級降級。在第三季度，應用分子公司的每股盈利為 0.65 美元，而去年同期則為 0.68 美元。該股價的 52 周高點為 14.94 美元，52 周低點為 0.39 美元。在上一個交易週期結束時，應用分子收盤 0.43 美元。
See all analyst ratings downgrades.
查看所有分析師評級降級。
Initiations
起始
Northland Capital Markets initiated coverage on The Lion Electric Co (NYSE:LEV) with an Outperform rating. The price target for Lion Electric is set to $5.00. Lion Electric earned $0.09 in the third quarter, compared to $0.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of $10.18 and a 52-week-low of $1.83. Lion Electric closed at $2.00 at the end of the last trading period.
北國資本市場開始覆蓋 雄獅電器公司 (紐約證券交易所代碼:LEV) 具有「跑贏大市」等級。獅子電氣的目標價格定為 5.00 美元。獅子電器在第三季的收入為 0.09 美元，去年同期則為 0.60 美元。目前，該股價的 52 周高點為 10.18 美元，52 周低點為 1.83 美元。獅子電氣在上一個交易週期結束時收盤 2.00 美元。
With a Buy rating, Chardan Capital initiated coverage on Gesher I Acquisition Corp (NASDAQ:GIAC). The price target seems to have been set at $13.00 for Gesher I Acquisition.
憑藉「買入」評級，查丹資本開始覆蓋 格夏收購股份有限公司 (納斯達克:賈克).Gesher I 收購的價格目標似乎已定為 13.00 美元。
Chardan Capital initiated coverage on Century Therapeutics Inc (NASDAQ:IPSC) with a Buy rating. The price target for Century Therapeutics is set to $19.00. Century Therapeutics earned $0.53 in the third quarter, compared to $0.48 in the year-ago quarter. The stock has a 52-week-high of $19.39 and a 52-week-low of $5.48. At the end of the last trading period, Century Therapeutics closed at $5.67.
夏丹資本開始覆蓋 世紀治療公司 （納斯達克：IPSC）與購買評級。世紀治療的價格目標設置為 19.00 美元。世紀治療在第三季度的收入為 0.53 美元，而去年同期則為 0.48 美元。該股票的 52 周高點為 19.39 美元，52 周低點為 5.48 美元。在上一個交易週期結束時，世紀治療學收盤價為 5.67 美元。
See all analyst ratings initiations.
查看所有分析師等級初始化。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧